Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

First-in-Human Gene Therapy Study of AAVhu37 Capsid Vector Technology in Severe Hemophilia A - BAY 2599023 has Broad Patient Eligibility and Stable and Sustained Long-Term Expression of FVIII

Steven W. Pipe, MD, Francesca Ferrante, MD, Muriel Reis, Sara Wiegmann, Claudia Lange, Manuela Braun, Lisa A Michaels

Blood (2020) 136 (Supplement 1): 44–45.

https://doi.org/10.1182/blood-2020-139803

Published: 2020

Journal Articles

Pharmacodynamics, Pharmacokinetics and Safety of Bay 1093884, an Antibody Directed Against Human TFPI, in Patients with Factor VIII or IX Deficiency (With and Without Inhibitors): A Phase 1 Study

Pratima Chowdary, MD, Toshko Jelev Lissitchkov, MD, Stefan Willmann, Dr, Stephan Schwers, PhD, Lisa A. Michaels, Anita Shah

Blood (2018) 132 (Supplement 1): 1176.

https://doi.org/10.1182/blood-2018-99-114683

Published: 2018

Journal Articles

Bay 94-9027, a Site-Specifically Pegylated Recombinant Factor VIII: Preliminary Results from an International Comparative Laboratory Field Study

Nikki Church, Lilley Leong, Yvonne Katterle, Yadagiri Rao Danda, Hannes-Friedrich Ulbrich, Iris Noerenberg, Stefan Bruns, Lisa A. Michaels

Blood (2016) 128 (22): 2587.

https://doi.org/10.1182/blood.V128.22.2587.2587

Published: 2016

Journal Articles

Bleeding Phenotype with Various Bay 94-9027 Dosing Regimens: Subanalyses from the Protect VIII Study

Lisa N. Boggio, Walter Hong, Maria Wang, M. Elaine Eyster, MD, Lisa A. Michaels

Blood (2014) 124 (21): 1526.

https://doi.org/10.1182/blood.V124.21.1526.1526

Published: 2014

Journal Articles

Risk for Post Thrombotic Syndrome (PTS) Development in Children with Extremity Deep Venous Thrombosis (DVT): Results of the US Centers for Disease Control and Prevention (CDC) Pediatric Thrombosis and Hemostasis Centers.

Marilyn J. Manco-Johnson, Michele G. Beckman, MPH, Neil A. Goldenberg, MD, PhD, Courtney Thornburg, MD, MS, Lisa A. Michaels, MD, Steven W. Pipe, MD, Stephan Moll, MD, Vilmarie Rodriquez, MD, Roshni Kulkarni

Blood (2009) 114 (22): 4000.

https://doi.org/10.1182/blood.V114.22.4000.4000

Published: 2009

Journal Articles

The CDC Hemostasis and Thrombosis Centers (HTC) Pilot Sites: Data From the Pediatric Registry.

Lisa A Michaels, MD, Michele Beckman, MPH, Courtney Thornburg, MD, MS, Kristy Marquez, MPH, Roshni Kulkarni, MD, Steven W. Pipe, MD, Stephan Moll, MD, Marilyn Manco-Johnson, MD

Blood (2009) 114 (22): 2990.

https://doi.org/10.1182/blood.V114.22.2990.2990

Published: 2009

Journal Articles

Age and the Prevalence of Bleeding Disorders in Women Presenting with Menorrhagia.

Claire S. Philipp, MD, Ambarina Faiz, MD, MPH, Nicole Dowling, PhD, Anne Dilley, PHD, Lisa A. Michaels, MD, Charletta Ayers, MD, MPH, Connie H. Miller, PhD, Gloria Bachmann, MD, Bruce Evatt, MD, Parvin Saidi, MD

Blood (2004) 104 (11): 3080.

https://doi.org/10.1182/blood.V104.11.3080.3080

Published: 2004

Journal Articles

Serum Levels of Substance P Are Elevated in Patients With Sickle Cell Disease and Increase Further During Vaso-Occlusive Crisis

Lisa A. Michaels, Kwaku Ohene-Frempong, Huaqing Zhao, Steven D. Douglas

Blood (1998) 92 (9): 3148–3151.

https://doi.org/10.1182/blood.V92.9.3148

Published: 1998

NARROW

First-in-Human Gene Therapy Study of AAVhu37 Capsid Vector Technology in Severe Hemophilia A - BAY 2599023 has Broad Patient Eligibility and Stable and Sustained Long-Term Expression of FVIII

Pharmacodynamics, Pharmacokinetics and Safety of Bay 1093884, an Antibody Directed Against Human TFPI, in Patients with Factor VIII or IX Deficiency (With and Without Inhibitors): A Phase 1 Study

Bay 94-9027, a Site-Specifically Pegylated Recombinant Factor VIII: Preliminary Results from an International Comparative Laboratory Field Study

Bleeding Phenotype with Various Bay 94-9027 Dosing Regimens: Subanalyses from the Protect VIII Study

Risk for Post Thrombotic Syndrome (PTS) Development in Children with Extremity Deep Venous Thrombosis (DVT): Results of the US Centers for Disease Control and Prevention (CDC) Pediatric Thrombosis and Hemostasis Centers.

The CDC Hemostasis and Thrombosis Centers (HTC) Pilot Sites: Data From the Pediatric Registry.

Age and the Prevalence of Bleeding Disorders in Women Presenting with Menorrhagia.

Serum Levels of Substance P Are Elevated in Patients With Sickle Cell Disease and Increase Further During Vaso-Occlusive Crisis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only